Acura Pharmaceuticals, Inc.

Isp Investments Inc.

Evident Id, Inc.

Abuse Deterrent Pharmaceuticals, LLC

Albert W Brzeczko

R Gary Hollenbeck

Ronald L Leech, Jr

Rachelle L Hall Yung

Robert Barnett Jones

John Alfred Doney

William David Thomas

Damian A Starosielsky

Nathan S Rowe

An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.

Methods and compositions for self-regulated release of active pharmaceutical ingredient

An abuse deterrent pharmaceutical composition including a drug susceptible to abuse, a first acid soluble ingredient, a first buffering ingredient, and a delayed release buffering component.

Methods and compositions for self-regulated release of active pharmaceutical ingredients

A computer-implemented method for managing a personal data store is described for binding one or more identities of different types associated with a user. The computer-implemented method is implemented in a trust system including one or more processing devices communicatively coupled to a network. The computer-implemented method includes receiving one or more self-asserted first attributes by the user and second attributes asserted by an Attribute Provider; utilizing one or more of the first attributes and the second attributes as inputs to obtain and/or produce one or more cryptographically signed attributes signed by an associated Attribute Provider; storing the first attributes, the second attributes, and the one or more cryptographically signed attributes in a personal data store associated with the user; and utilizing one or more of the first attributes, the second attributes, and the one or more cryptographically signed attributes to respond to a request from a Relying Party.

Identity binding systems and methods in a personal data store in an online trust system

A method for preparing solid materials is described. One aspect of the method includes the steps of (a) providing a feedstock comprising an organic material(s) in a solvent system containing a non-solvent for the organic material at an elevated temperature and/or pressure above ambient conditions, (b) distributing the feedstock into either droplets or a film, and (d) evaporating the solvent system from the feedstock.

Formulation process method to produce spray dried products

Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse comprising at least 10% by weight hydroxypropylcellulose; polyethylene oxide; and a disintegrant selected from the group consisting of crospovidone, sodium starch glycolate and croscarmellose sodium; wherein the ratio of hydroxypropylcellulose to polyethylene oxide on a weight basis is between about 10:1 and 1:10.

Growing community of inventors

Roswell, GA, United States of America

Albert W Brzeczko